vs
Side-by-side financial comparison of Insulet Corporation (PODD) and PRICESMART INC (PSMT). Click either name above to swap in a different company.
PRICESMART INC is the larger business by last-quarter revenue ($1.4B vs $783.7M, roughly 1.8× Insulet Corporation). Insulet Corporation runs the higher net margin — 13.0% vs 2.9%, a 10.1% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs 9.9%). Insulet Corporation produced more free cash flow last quarter ($48.2M vs $32.6M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs 3.5%).
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
PRICESMART INCPSMTEarnings & Financial Report
PriceSmart, Inc. is a United States based operator of membership warehouse clubs in Central America, the Caribbean, and South America. PriceSmart was founded by Sol and Robert Price, founders of Price Club; Robert Price is chairman of the board.
PODD vs PSMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $783.7M | $1.4B |
| Net Profit | $101.6M | $40.2M |
| Gross Margin | 72.6% | 17.7% |
| Operating Margin | 18.7% | 4.6% |
| Net Margin | 13.0% | 2.9% |
| Revenue YoY | 31.2% | 9.9% |
| Net Profit YoY | 0.9% | 7.3% |
| EPS (diluted) | $1.42 | $1.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $783.7M | $1.4B | ||
| Q3 25 | $706.3M | $1.3B | ||
| Q2 25 | $649.1M | $1.3B | ||
| Q1 25 | $569.0M | $1.4B | ||
| Q4 24 | $597.5M | $1.3B | ||
| Q3 24 | $543.9M | $1.2B | ||
| Q2 24 | $488.5M | $1.2B | ||
| Q1 24 | $441.7M | $1.3B |
| Q4 25 | $101.6M | $40.2M | ||
| Q3 25 | $87.6M | $31.5M | ||
| Q2 25 | $22.5M | $35.2M | ||
| Q1 25 | $35.4M | $43.8M | ||
| Q4 24 | $100.7M | $37.4M | ||
| Q3 24 | $77.5M | $29.1M | ||
| Q2 24 | $188.6M | $32.5M | ||
| Q1 24 | $51.5M | $39.3M |
| Q4 25 | 72.6% | 17.7% | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 69.7% | — | ||
| Q1 25 | 71.9% | 17.1% | ||
| Q4 24 | 72.1% | 17.4% | ||
| Q3 24 | 69.3% | — | ||
| Q2 24 | 67.7% | — | ||
| Q1 24 | 69.5% | — |
| Q4 25 | 18.7% | 4.6% | ||
| Q3 25 | 16.7% | 4.0% | ||
| Q2 25 | 18.7% | 4.3% | ||
| Q1 25 | 15.6% | 4.8% | ||
| Q4 24 | 18.3% | 4.6% | ||
| Q3 24 | 16.2% | 4.0% | ||
| Q2 24 | 11.2% | 4.1% | ||
| Q1 24 | 12.9% | 4.9% |
| Q4 25 | 13.0% | 2.9% | ||
| Q3 25 | 12.4% | 2.4% | ||
| Q2 25 | 3.5% | 2.7% | ||
| Q1 25 | 6.2% | 3.2% | ||
| Q4 24 | 16.9% | 3.0% | ||
| Q3 24 | 14.2% | 2.4% | ||
| Q2 24 | 38.6% | 2.6% | ||
| Q1 24 | 11.7% | 3.0% |
| Q4 25 | $1.42 | $1.29 | ||
| Q3 25 | $1.24 | $1.02 | ||
| Q2 25 | $0.32 | $1.14 | ||
| Q1 25 | $0.50 | $1.45 | ||
| Q4 24 | $1.38 | $1.21 | ||
| Q3 24 | $1.08 | $0.94 | ||
| Q2 24 | $2.59 | $1.08 | ||
| Q1 24 | $0.73 | $1.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $320.6M |
| Total DebtLower is stronger | $930.8M | $180.3M |
| Stockholders' EquityBook value | $1.5B | $1.3B |
| Total Assets | $3.2B | $2.4B |
| Debt / EquityLower = less leverage | 0.61× | 0.14× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $320.6M | ||
| Q3 25 | — | $314.2M | ||
| Q2 25 | — | $262.4M | ||
| Q1 25 | — | $247.3M | ||
| Q4 24 | — | $222.2M | ||
| Q3 24 | — | $225.5M | ||
| Q2 24 | — | $228.2M | ||
| Q1 24 | — | $264.2M |
| Q4 25 | $930.8M | $180.3M | ||
| Q3 25 | $934.9M | $186.6M | ||
| Q2 25 | $939.0M | $103.1M | ||
| Q1 25 | $1.6B | $107.1M | ||
| Q4 24 | $1.3B | $115.6M | ||
| Q3 24 | $1.4B | $130.4M | ||
| Q2 24 | $1.4B | $135.1M | ||
| Q1 24 | $1.4B | $140.0M |
| Q4 25 | $1.5B | $1.3B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.5B | $1.2B | ||
| Q1 25 | $1.3B | $1.2B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $1.1B | $1.1B | ||
| Q2 24 | $998.4M | $1.1B | ||
| Q1 24 | $790.7M | $1.1B |
| Q4 25 | $3.2B | $2.4B | ||
| Q3 25 | $3.0B | $2.3B | ||
| Q2 25 | $3.5B | $2.1B | ||
| Q1 25 | $3.5B | $2.1B | ||
| Q4 24 | $3.1B | $2.1B | ||
| Q3 24 | $3.0B | $2.0B | ||
| Q2 24 | $2.9B | $2.0B | ||
| Q1 24 | $2.6B | $2.0B |
| Q4 25 | 0.61× | 0.14× | ||
| Q3 25 | 0.68× | 0.15× | ||
| Q2 25 | 0.64× | 0.08× | ||
| Q1 25 | 1.21× | 0.09× | ||
| Q4 24 | 1.07× | 0.10× | ||
| Q3 24 | 1.21× | 0.12× | ||
| Q2 24 | 1.36× | 0.12× | ||
| Q1 24 | 1.72× | 0.13× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.3M | $71.2M |
| Free Cash FlowOCF − Capex | $48.2M | $32.6M |
| FCF MarginFCF / Revenue | 6.2% | 2.4% |
| Capex IntensityCapex / Revenue | 17.2% | 2.8% |
| Cash ConversionOCF / Net Profit | 1.80× | 1.77× |
| TTM Free Cash FlowTrailing 4 quarters | $377.7M | $125.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $183.3M | $71.2M | ||
| Q3 25 | $125.7M | $82.1M | ||
| Q2 25 | $196.5M | $52.8M | ||
| Q1 25 | $63.8M | $87.9M | ||
| Q4 24 | $147.7M | $38.5M | ||
| Q3 24 | $98.5M | $41.8M | ||
| Q2 24 | $96.5M | $38.1M | ||
| Q1 24 | $87.6M | $86.6M |
| Q4 25 | $48.2M | $32.6M | ||
| Q3 25 | $100.1M | $25.6M | ||
| Q2 25 | $177.9M | $14.0M | ||
| Q1 25 | $51.5M | $53.2M | ||
| Q4 24 | $94.1M | $10.3M | ||
| Q3 24 | $71.8M | $15.2M | ||
| Q2 24 | $74.0M | $-308.0K | ||
| Q1 24 | $65.5M | $16.4M |
| Q4 25 | 6.2% | 2.4% | ||
| Q3 25 | 14.2% | 1.9% | ||
| Q2 25 | 27.4% | 1.1% | ||
| Q1 25 | 9.1% | 3.9% | ||
| Q4 24 | 15.7% | 0.8% | ||
| Q3 24 | 13.2% | 1.2% | ||
| Q2 24 | 15.1% | -0.0% | ||
| Q1 24 | 14.8% | 1.3% |
| Q4 25 | 17.2% | 2.8% | ||
| Q3 25 | 3.6% | 4.2% | ||
| Q2 25 | 2.9% | 2.9% | ||
| Q1 25 | 2.2% | 2.5% | ||
| Q4 24 | 9.0% | 2.2% | ||
| Q3 24 | 4.9% | 2.2% | ||
| Q2 24 | 4.6% | 3.1% | ||
| Q1 24 | 5.0% | 5.4% |
| Q4 25 | 1.80× | 1.77× | ||
| Q3 25 | 1.43× | 2.60× | ||
| Q2 25 | 8.73× | 1.50× | ||
| Q1 25 | 1.80× | 2.01× | ||
| Q4 24 | 1.47× | 1.03× | ||
| Q3 24 | 1.27× | 1.44× | ||
| Q2 24 | 0.51× | 1.17× | ||
| Q1 24 | 1.70× | 2.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
PSMT
| Fresh Foods | $454.9M | 33% |
| Caribbean Operations Segment | $396.5M | 29% |
| Colombia Operations Segment | $204.1M | 15% |
| Hardlines | $162.6M | 12% |
| Softlines | $99.8M | 7% |
| ship Income Member | $24.5M | 2% |
| Health Services | $14.5M | 1% |
| Other Revenue And Income | $4.2M | 0% |
| United States Operations Segment | $510.0K | 0% |
| Export Sales | $359.0K | 0% |
